Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB ZYDUS LIFESCIENCES DR. REDDYS LAB/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 20.1 20.8 97.0% View Chart
P/BV x 3.8 2.6 147.3% View Chart
Dividend Yield % 0.7 0.6 119.5%  

Financials

 DR. REDDYS LAB   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-22
ZYDUS LIFESCIENCES
Mar-22
DR. REDDYS LAB/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs5,614674 833.3%   
Low Rs3,655331 1,104.2%   
Sales per share (Unadj.) Rs1,294.6149.1 868.2%  
Earnings per share (Unadj.) Rs126.922.7 558.5%  
Cash flow per share (Unadj.) Rs196.929.7 663.3%  
Dividends per share (Unadj.) Rs30.002.50 1,200.0%  
Avg Dividend yield %0.60.5 130.1%  
Book value per share (Unadj.) Rs1,145.8166.1 690.0%  
Shares outstanding (eoy) m166.431,023.74 16.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.63.4 106.3%   
Avg P/E ratio x36.522.1 165.2%  
P/CF ratio (eoy) x23.516.9 139.1%  
Price / Book Value ratio x4.03.0 133.7%  
Dividend payout %23.611.0 214.9%   
Avg Mkt Cap Rs m771,272514,277 150.0%   
No. of employees `000NANA-   
Total wages/salary Rs m38,85821,777 178.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m215,452152,652 141.1%  
Other income Rs m4,8472,354 205.9%   
Total revenues Rs m220,299155,006 142.1%   
Gross profit Rs m37,67434,427 109.4%  
Depreciation Rs m11,6527,130 163.4%   
Interest Rs m9581,270 75.4%   
Profit before tax Rs m29,91128,381 105.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,7895,117 171.8%   
Profit after tax Rs m21,12223,264 90.8%  
Gross profit margin %17.522.6 77.5%  
Effective tax rate %29.418.0 163.0%   
Net profit margin %9.815.2 64.3%  
BALANCE SHEET DATA
Current assets Rs m177,880122,614 145.1%   
Current liabilities Rs m97,65878,394 124.6%   
Net working cap to sales %37.229.0 128.5%  
Current ratio x1.81.6 116.5%  
Inventory Days Days5693 60.1%  
Debtors Days Days11380 141.6%  
Net fixed assets Rs m106,819144,382 74.0%   
Share capital Rs m8321,024 81.3%   
"Free" reserves Rs m189,859168,972 112.4%   
Net worth Rs m190,691169,996 112.2%   
Long term debt Rs m5,7463,621 158.7%   
Total assets Rs m284,699266,996 106.6%  
Interest coverage x32.223.3 138.0%   
Debt to equity ratio x00 141.5%  
Sales to assets ratio x0.80.6 132.4%   
Return on assets %7.89.2 84.4%  
Return on equity %11.113.7 80.9%  
Return on capital %15.717.1 92.0%  
Exports to sales %47.10-   
Imports to sales %18.814.3 130.9%   
Exports (fob) Rs m101,544NA-   
Imports (cif) Rs m40,40121,869 184.7%   
Fx inflow Rs m101,54463,065 161.0%   
Fx outflow Rs m40,40121,869 184.7%   
Net fx Rs m61,14341,196 148.4%   
CASH FLOW
From Operations Rs m28,10821,041 133.6%  
From Investments Rs m-26,38711,544 -228.6%  
From Financial Activity Rs m-2,422-8,683 27.9%  
Net Cashflow Rs m3223,729 0.1%  

Share Holding

Indian Promoters % 26.7 75.0 35.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 50.7 16.2 312.6%  
FIIs % 27.3 2.5 1,087.3%  
ADR/GDR % 10.5 0.0 -  
Free float % 62.8 25.0 250.9%  
Shareholders   246,788 370,396 66.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   SUN PHARMA    CIPLA    LUPIN    AUROBINDO PHARMA    PIRAMAL ENTERPRISES    


More on Dr. Reddys vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs Cadila Healthcare Share Price Performance

Period Dr. Reddys Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.28% 0.32% -0.93%
1-Month 2.84% 2.15% -4.27%
1-Year -0.36% 6.48% -10.68%
3-Year CAGR 11.52% 18.59% 17.23%
5-Year CAGR 15.61% 1.25% 9.48%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 23.6%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms 910 Points | Titan & Adani Ports Rally 6% | 5 Reasons Why Indian Markets are Rising Sensex Today Zooms 910 Points | Titan & Adani Ports Rally 6% | 5 Reasons Why Indian Markets are Rising(Closing)

After opening the day higher, Indian share markets continued their momentum throughout the day and ended on a firm footing.